Abstract
This study explored the effects of pharmacological activation of branched chain amino acid (BCAA) catabolism using BT2 to prevent nephrotoxic acute kidney injury (AKI) in mice. Our results indicate that activation of BCAA catabolism protects against nephrotoxic AKI, in association with reduced BCAA accumulation, reduced mammalian target of rapamycin protein complex 1 signaling, and improved mitochondrial bioenergetics.
Funding Information
  • American Heart Association (Career Development Award)
  • American Society of Nephrology (Joseph V. Bonventre Research Scholar Award)
  • Dialysis Clinics
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NYC-Train KUHR)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK133238)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK112984)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK121846)
  • U.S. Department of Veterans Affairs (I01BX003698)
  • U.S. Department of Veterans Affairs (IS1BX004815)

This publication has 44 references indexed in Scilit: